首页> 外文期刊>Journal of Breast Cancer >Breast Cancer Screening: A Medical Audit of the Screening Mammography Performed at One Institution for 10 Years
【24h】

Breast Cancer Screening: A Medical Audit of the Screening Mammography Performed at One Institution for 10 Years

机译:乳腺癌筛查:在一家机构进行了10年的乳房X线筛查的医学审计

获取原文
获取外文期刊封面目录资料

摘要

Purpose Screening for breast cancer has constantly been increasing since the benefit of screening for breast cancers was established. The purpose of this study was to investigate the efficacy of annual breast cancer screening at one institution for 10 years by conducting a medical audit. Methods From March 1995 to July 2004, we performed 110,588 annual clinical examinations and mammographies on 58,024 women, who wanted to undergo breast cancer screening. Two hundred fourteen breast cancers were detected during screening, and one hundred sixty one of these patients were operated on. We then compared these results with the ideal rates for medical audits. Results Of the 110,588 cases that were screened, the recall rate for further examination was 12.1% (n=13,423). The biopsy rate was 1.01% (n=1,116). Two hundred fourteen breast cancers were detected for a detection rate of 0.19%. The percent of stage 0 cancer among all the cancer was 23.6%, stage I was 40.4%, stage IIa was 19.9%, stage IIb and IIIa were a combined 6.2%, stage IIIc was 3.1%, and stage IV was 0.6%. The positive predictive value (PPV) based on the abnormal findings on the screening examinations was 1.6% (PPV1). The PPV when a biopsy or surgical consultation was recommended was 15.1% (PPV2). The percent of tumor found as stage 0 or I was 64% (103/161). The tumor found as minimal cancer (stage 0 or tumor lesser than 1 cm) was 38.5% (62/161). There were 38 cases of axillary lymph node metastasis (23.6%). The number of cases of cancers found per 1,000 cases was 1.7. The prevalence of cancer found per 1,000 first examinations was 2.3. The incidental cancer found per 1,000 follow-up examinations was 1.2. The recall rate for further evaluation was 12.1%. These results were compatible with the ideal rates for medical audits, except for the recall rate, the PPV1, the PPV2, and the cancers found per 1,000 cases. Conclusion On the base of these results, breast cancer screening was properly performed in this institution. Breast cancer screening using a clinical examination and a mammography is effective for the early detection of breast cancer.
机译:目的自建立乳腺癌筛查的好处以来,乳腺癌筛查一直在不断增加。这项研究的目的是通过进行医疗审核来调查在一家机构进行10年的年度乳腺癌筛查的有效性。方法从1995年3月至2004年7月,我们对58,024名想进行乳腺癌筛查的女性进行了110,588例年度临床检查和X线摄影检查。在筛查期间检测到214例乳腺癌,其中161例接受了手术。然后,我们将这些结果与理想的医疗审核率进行了比较。结果筛查的110588例病例中,进一步检查的召回率为12.1%(n = 13423)。活检率为1.01%(n = 1,116)。检出214例乳腺癌,检出率为0.19%。在所有癌症中,0期癌症的百分比为23.6%,I期为40.4%,IIa期为19.9%,IIb和IIIa期相加为6.2%,IIIc期为3.1%,IV期为0.6%。基于筛查检查异常发现的阳性预测值(PPV)为1.6%(PPV1)。建议进行活检或手术咨询时的PPV为15.1%(PPV2)。在0期或I期发现的肿瘤百分比为64%(103/161)。发现为最小癌症(0期或小于1 cm的肿瘤)的肿瘤为38.5%(62/161)。腋窝淋巴结转移38例,占23.6%。每1000例癌症中发现的癌症病例数为1.7。每1000例首次检查中发现的癌症患病率为2.3。每1000例随访检查发现的偶然癌症为1.2。进一步评估的召回率为12.1%。这些结果与医疗审核的理想比率相符,除了召回率,PPV1,PPV2和每千个病例中发现的癌症之外。结论根据这些结果,在该机构正确进行了乳腺癌筛查。使用临床检查和乳房X线照相术对乳腺癌进行筛查对早期发现乳腺癌有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号